MARKET OVERVIEW
Communicable diseases are known as infectious diseases. These transmissible diseases cause illnesses resulting from the infection, presence, and growth of pathogenic (capable of causing disease) biological agents in individual human or other animal hosts. These infections may be asymptomatic (without symptoms) or severe and fatal. Communicable diseases may transmit through contact with infected fluids, insect bites, contaminated surfaces, water, foods, and the air.
MARKET SCOPE
The "Communicable Disease Treatment Market Analysis to 2028" is a specialized and in-depth examination of the healthcare industry, with a particular emphasis on regional market trend analysis. The purpose of this report is to provide an overview of the communicable disease treatment market, as well as detailed market segmentation based on treatment type, transmission, and infection type. Additionally, the report offers key statistics on the market status of the leading communicable disease treatment market players, as well as key market trends and opportunities.
MARKET SEGMENTATION
- Based on treatment type, the market is segmented into vaccines, therapeutic drugs, and others.
- Based on transmission, the market is segmented into direct contact and indirect contact.
- Based on infection type, the market is segmented into bacterial infection, fungal infection, and viral infection.
MARKET DYNAMICS
Drivers-
- Rising incidences of infectious diseases
- High susceptibility towards viral infections.
- Extensive R&D efforts by pharmaceutical companies to develop novel therapies for communicable disease treatment are expected to fuel the market growth.
Restraint-
- Lack of awareness and knowledge about communicable diseases.
- High cost of treatment for communicable diseases is expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2022 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The communicable disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally, along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, Asia Pacific, Middle East & Africa, and South America after evaluating political, economic, social, and technological factors affecting the communicable disease treatment market in these regions.
Impact of COVID-19 on the Communicable Disease Treatment Market
The limited availability of resources, including trained staff and medical equipment, and the burden of infectious diseases harm the overall healthcare system. In 2020, the COVID-19 pandemic significantly impacted the delivery and accessibility of social services, education, health and nutrition, healthcare spending, and well-being- and development-related businesses. The COVID-19 pandemic significantly propelled the growth of the communicable disease treatment market. According to a report in November 2020 by Organization for Economic Co-operation and Development (OECD), prevention and treatment services for COVID-19, HIV, hepatitis, and other communicable disease have significantly increased since the pandemic began. Overall, there has been a positive impact on the communicable disease treatment market during the COVID-19 period due to the rise in demand for drugs and treatment for infectious diseases, including COVID-19 infection.
MARKET PLAYERS
The report covers key developments in the communicable disease treatment market with focus on two main strategies such as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies that includes new product launches, product approvals by the authorized bodies, and others such as patents and events. Inorganic growth strategies activities normally include strategic acquisitions and partnership & collaborations between the companies. These activities have paved way for the expansion of business and customer base of market players. The market payers from communicable disease treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for communicable disease treatment globally.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the communicable disease treatment market. Also, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last three years, and key development in the past five years.
- Bayer AG
- Lupin
- Sanofi
- GlaxoSmithKline
- Pfizer
- Johnson and Johnson
- Sun Pharmaceutical Industries Ltd.
- Roche
- Novartis
- Merck
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.